Alcohol Ups Risk for Intracranial Hemorrhage in Seniors With Fall-Related Head Injury
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 15, 2024 -- Self-reported alcohol use appears to be associated with a higher risk for intracranial hemorrhage (ICH) in older adults with a fall-related head injury, according to a study published online July 31 in the Journal of the American College of Emergency Physicians Open.
Alexander Zirulnik, M.D., from Harvard Medical School in Boston, and colleagues examined the association between self-reported alcohol use and the prevalence of ICH in older emergency department head trauma patients. The analysis included 3,128 participants in the Geriatric Head Trauma Short Term Outcomes Project.
The researchers found that 18.2 percent of participants reported alcohol use (10.3 percent occasional use, 1.9 percent weekly use, and 6.0 percent daily use). In patients who used alcohol, ICH was more common (20.5 percent for occasional, 22.0 percent for weekly, and 25.1 percent for daily alcohol use versus 12.0 percent for nonusers). Frequency of alcohol use was independently associated with ICH, when adjusting for patient and head injury risk factors (adjusted odds ratios for occasional, weekly, and daily alcohol use were 2.0, 2.1, and 2.5, respectively), indicating a dose-response effect.
"Fall prevention strategies may need to consider alcohol mitigation as a modifiable risk factor," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-16 01:15
Read more
- Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
- CDC Confirms Second Human Bird Flu Case in Missouri With No Known Exposure to Farm Animals
- Election Fears Are Compromising the Sleep Health of Americans
- Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
- Dementia Death Rates in U.S. Older Adults Fluctuated From 2018 to 2022
- Heat Waves Linked to Adverse Health Outcomes for Seniors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions